Key Takeaways
- In 2022, an estimated 1.7 million people aged 12 or older in the United States had a hydrocodone use disorder in the past year, equating to 0.6% of the total population in that age group
- Hydrocodone was involved in 14,716 overdose deaths in the US in 2021, accounting for 8.3% of all drug overdose fatalities that year
- From 2010 to 2020, the prevalence of hydrocodone misuse among US high school seniors increased from 4.7% to 6.2%
- White non-Hispanic adults have a 2.5 times higher rate of hydrocodone use disorder compared to Black adults
- Males aged 18-25 exhibit 3.1% past-year hydrocodone misuse, 1.7 times female rate
- Individuals with chronic pain history are 4.2 times more likely to develop hydrocodone addiction
- Hydrocodone addiction leads to respiratory depression in 28% of overdose cases
- Chronic hydrocodone use causes hyperalgesia in 35% of long-term users per studies
- 42% of hydrocodone addicts develop tolerance requiring dose escalation within 6 months
- Only 40-60% of patients in medication-assisted treatment for hydrocodone addiction remain abstinent at 6 months
- Buprenorphine reduces hydrocodone relapse risk by 50% in first year of treatment
- 12-step programs show 25% one-year sobriety rate for hydrocodone addicts
- Annual US healthcare costs for hydrocodone addiction treatment exceed $78 billion in 2022
- Lost productivity from hydrocodone use disorder totals $504 billion yearly in US
- Each hydrocodone overdose death incurs $1.02 million in societal costs including medical and lost wages
Hydrocodone addiction is a widespread crisis affecting millions of Americans and causing thousands of overdose deaths annually.
Demographics and Risk Factors
Demographics and Risk Factors Interpretation
Economic and Social Impact
Economic and Social Impact Interpretation
Health Effects and Consequences
Health Effects and Consequences Interpretation
Prevalence and Incidence
Prevalence and Incidence Interpretation
Treatment and Recovery
Treatment and Recovery Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2CDCcdc.govVisit source
- Reference 3MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 4NIDAnida.nih.govVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6DEAdea.govVisit source
- Reference 7JAMANETWORKjamanetwork.comVisit source
- Reference 8EPAepa.govVisit source
- Reference 9VAva.govVisit source
- Reference 10CAHCcahc.netVisit source
- Reference 11QUESTDIAGNOSTICSquestdiagnostics.comVisit source
- Reference 12HCUP-UShcup-us.ahrq.govVisit source
- Reference 13AAPCCaapcc.orgVisit source
- Reference 14NATUREnature.comVisit source
- Reference 15PTSDptsd.va.govVisit source
- Reference 16BMJbmj.comVisit source
- Reference 17NIMHnimh.nih.govVisit source
- Reference 18AHAJOURNALSahajournals.orgVisit source
- Reference 19NEJMnejm.orgVisit source
- Reference 20GASTROJOURNALgastrojournal.orgVisit source
- Reference 21JCSMjcsm.aasm.orgVisit source
- Reference 22UPTODATEuptodate.comVisit source
- Reference 23ASAMasam.orgVisit source
- Reference 24FDAfda.govVisit source
- Reference 25ASPEaspe.hhs.govVisit source






